Related Experiment Video
Updated: Sep 29, 2025

A Simple Flow Cytometric Method to Measure Glucose Uptake and Glucose Transporter Expression for Monocyte Subpopulations in Whole Blood
Published on: August 12, 2016
The Effects of Increased Glucose Level and Glycolysis on SARS CoV-2 Infection
Fatma Ozlem Zurnaci1,2, Mustafa Guzel1,3,4
1Research Institute for Health Sciences and Technologies (SABITA), Center of Drug Discovery and Development, Istanbul Medipol University, Kavacik-Beykoz / Istanbul, 34810, Turkey.
Abstract:
COVID-19 has entered our lives as an infection with high mortality rates. Although the vaccination process has provided benefits, the death toll remains frightening worldwide. Therefore, drugs and combined therapies that can be used against COVID-19 infection are still being investigated. Most of these antiviral medications are investigational drug candidates that are still in clinical trials. In this context, holistic and different approaches for the treatment of COVID-19, including prophylactic use of natural medicines, are under investigation and may offer potential treatment options due to the fact that this is still an unmet medical need of the world. Thus, inhibiting the increased glycolysis in COVID-19 infection with glycolysis inhibitors may be beneficial for patient survival. This short review highlights the potential benefits of glycolysis inhibition as well as controlling the elevated glucose levels in patients with COVID-19.
Insights
Investigating glycolysis inhibitors for COVID-19 treatment shows promise. Targeting increased glycolysis and high glucose levels may improve patient survival rates for this critical illness.
Area of Science:
- Biochemistry
- Virology
- Pharmacology
Background:
- COVID-19 remains a global health threat with significant mortality.
- Vaccination has helped, but effective treatments are still needed.
- Elevated glycolysis is observed in COVID-19 patients.
Purpose of the Study:
- To review the potential benefits of inhibiting glycolysis in COVID-19.
- To explore controlling elevated glucose levels in COVID-19 patients.
Main Methods:
- Literature review of studies on COVID-19 metabolism.
- Analysis of the role of glycolysis in viral infections.
- Examination of potential therapeutic strategies targeting glucose metabolism.
Main Results:
- Increased glycolysis is a metabolic hallmark of severe COVID-19.
- Glycolysis inhibitors may offer a novel therapeutic approach.
- Controlling hyperglycemia is crucial for patient outcomes.
Conclusions:
- Inhibiting glycolysis presents a promising strategy for COVID-19 treatment.
- Targeting metabolic pathways could improve survival rates.
- Further research into glycolysis inhibitors is warranted.
More Related Videos
Related Concept Videos
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
What is Glycolysis?
Cells make energy by breaking down macromolecules. Cellular respiration is the biochemical process that converts "food energy" (from the chemical bonds of macromolecules) into chemical energy in the form of adenosine triphosphate (ATP). The first step of this tightly regulated and intricate process is glycolysis. The word glycolysis originates from the Latin glyco (sugar) and lysis (breakdown). Glycolysis serves two main intracellular functions: generating ATP and generating...
Outcomes of Glycolysis
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
Glycolysis: Preparatory Phase
Glycolysis
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...

